Essence MD Research LLC | Naples, FL

Research site

About

Clinical Research Site

Location

800 Goodlette-Frank Rd., North, #310, Naples, Florida, United States of America

Website

https://emdresearch.com/

Site insights

Top conditions

Top treatments

Treprostinil Palmitil

Depemokimab

BI 1291583

Frevecitinib

KN-002

Mepolizumab

CSL787

GSK3862995B

Tozorakimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Jazmin Izquierdo

Verified by this site

Active trials

14 of 14 total trials

A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma (PANAIRAMA)

A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Ast...

Begins enrollment this month

Severe Asthma

Drug: Placebo

Drug: Frevecitinib

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease (BEconneCTD-ILD)

Interstitial lung disease (ILD) is a lung condition resulting in inflammation and stiffening of the lung, often associated with connective tissue dis...

Enrolling

Lung Diseases, Interstitial

Other: Placebo

Biological: Belimumab

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

This study is designed to find out how effective and safe a new drug, GSK3862995B, is for adult participants with bronchiectasis, a chronic lung dise...

Not yet enrolling

Bronchiectasis

Drug: GSK3862995B

Drug: Placebo

Locations recently updated

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization (CLEAR)

AZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.

Enrolling

Bronchiectasis With Pseudomonas Aeruginosa Colonization

Biological: AZD0292

Other: Placebo

New

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not...

Not yet enrolling

Overweight

Obstructive Sleep Apnoea

Drug: Placebo (matched to NNC0487-0111)

Drug: NNC0487-0111

New

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with overweight or obesity, and obstructive sleep apnoea...

Not yet enrolling

Overweight

Obstructive Sleep Apnoea

Drug: NNC0487-0111

Drug: Placebo (matched to NNC0487-0111)

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

The primary objective of this study is to evaluate the safety and tolerability of the long-term use of TPIP in participants with PH-ILD from Study IN...

Not yet enrolling

Pulmonary Hypertension

Interstitial Lung Disease

Drug: Treprostinil Palmitil Inhalation Powder

Drug: Placebo

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safet...

Enrolling

Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Drug: Placebo

Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

This study is a phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose range finding study designed to explore the...

Enrolling

Non-cystic Fibrosis Bronchiectasis

Drug: Placebo

Biological: CSL787

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations (MIRANDA)

The purpose of this Phase III study is to evaluate the efficacy and safety of tozorakimab administered subcutaneously (SC) in adult participants with...

Active, not recruiting

Chronic Obstructive Pulmonary Disease (COPD)

Drug: Placebo

Drug: Tozorakimab

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (PALM-ILD)

The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in ad...

Enrolling

Pulmonary Hypertension

Interstitial Lung Disease

Drug: Placebo

Drug: Treprostinil Palmitil Inhalation Powder

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation (VIGILANT)

Depemokimab is being developed as a treatment for individuals with moderate to severe Chronic Obstructive Pulmonary Disorder (COPD). The aim of this...

Enrolling

Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Drug: Placebo

REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study

This is a prospective, real-world, single arm, global, multi-centre study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to ach...

Active, not recruiting

Asthma

Other: Spirometry

Drug: Mepolizumab

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

This study is open to adults and adolescents aged 12 to under 18 with bronchiectasis. People can participate in this study if they produce sputum and...

Enrolling

Bronchiectasis

Drug: Placebo matching BI 1291583

Drug: BI 1291583